Jason Cavalier Lyra Therapeutics, Inc. (LYRA) insider trading activity

LYRA Quotes by TradingView

Jason Cavalier is Chief Financial Officer of Lyra Therapeutics, Inc.. Currently has a direct ownership of 519,316 shares of LYRA, which is worth approximately $4.74 Million. The most recent transaction as insider was on Jul 10, 2025, when has been sold 684 shares (Common Stock) at a price of $8.91 per share, resulting in proceeds of $6,094. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 519K
0.13% 3M change
n/a 12M change
Total Value Held $4.74 Million

Jason Cavalier Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 10 2025
SELL
Open market or private sale
$6,094 $8.91 p/Share
684 Reduced 0.13%
519,316 Common Stock
Jan 08 2025
BUY
Grant, award, or other acquisition
-
420,000 Added 44.68%
520,000 Common Stock
Oct 16 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock
JC

Jason Cavalier

Chief Financial Officer
Watertown, MA

Track Institutional and Insider Activities on LYRA

Follow Lyra Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYRA shares.

Notify only if

Insider Trading

Get notified when an Lyra Therapeutics, Inc. insider buys or sells LYRA shares.

Notify only if

News

Receive news related to Lyra Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LYRA